The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry
Abstract
Public policies designed to increase utilization of existing technologies may also affect incentives to develop new technologies. This paper investigates this phenomenon by examining policies designed to increase usage of preexisting vaccines. I find that these policies were associated with a 2.5-fold increase in clinical trials for new vaccines. For several diseases, the induced innovation is socially wasteful, though small in magnitude. In one case, however, the “dynamic” social welfare benefits from induced innovation exceed the policies' “static” benefits from increasing vaccination with existing technology. These findings underscore the importance of including technological progress in economic analysis of public policy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2019) · AEA Papers and Proceedings · doi:10.1257/pandp.109.612 · Cited by 10,902
How Much Should We Trust Differences-in-Differences Estimates?
Bertrand, M., Duflo, E., & Mullainathan, S. (2004) · The Quarterly Journal of Economics · doi:10.1162/003355304772839588 · Cited by 10,641
Journal of Economic Literature
(2019) · AEA Papers and Proceedings · doi:10.1257/pandp.109.633 · Cited by 7,468
The Quarterly Journal of Economics
Kuznets, S. (2024) · Business Cycle Theory, Part I Volume 4 · doi:10.4324/9781003549741-8 · Cited by 7,176
Schmookler, J. (1966) · Harvard University Press eBooks · doi:10.4159/harvard.9780674432833 · Cited by 3,101
Report of the Committee on Infectious Diseases
Nider, H. (1989) · Archives of Dermatology · doi:10.1001/archderm.1989.01670190156031 · Cited by 1,911
Medical Care Costs: How Much Welfare Loss?
Newhouse, J. P. (1992) · Journal of Economic Perspectives · doi:10.1257/jep.6.3.3 · Cited by 1,211
Cost of innovation in the pharmaceutical industry
DiMasi, J. A., Hansen, R. W., Grabowski, H. G., & Lasagna, L. (1991) · Journal of Health Economics · doi:10.1016/0167-6296(91)90001-4 · Cited by 754
The Induced Innovation Hypothesis and Energy-Saving Technological Change
Newell, R., Jaffe, A., & Stavins, R. (1998) · National Bureau of Economic Research · doi:10.3386/w6437 · Cited by 656
Does Government R&D Policy Mainly Benefit Scientists and Engineers?
Goolsbee, A. (1998) · National Bureau of Economic Research · doi:10.3386/w6532 · Cited by 485
Innovation Policy and the Economy
(2007) · The MIT Press eBooks · doi:10.7551/mitpress/3788.001.0001 · Cited by 455
Immunization Practices Advisory Committee (1991) · PsycEXTRA Dataset · doi:10.1037/e546382006-001 · Cited by 398
(2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00274-4 · Cited by 284
New technologies for making vaccines
Ellis, R. W. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00416-2 · Cited by 84
Vaccine R&D success rates and development times
Struck, M.-M. (1996) · Nature Biotechnology · doi:10.1038/nbt0596-591 · Cited by 58
Plotkin, S. A., Orenstein, W. A., & Bernstein, D. I. (1999) · Shock · doi:10.1097/00024382-199910000-00017 · Cited by 35
Your Money and Your Life: The Value of Health and What Affects It
Cutler, D., & Richardson, E. (1999) · National Bureau of Economic Research · doi:10.3386/w6895 · Cited by 29
New Vaccine Development: Establishing Priorities, vol 1: Diseases of Importance in the United States
Prince, A. M. (1986) · JAMA · doi:10.1001/jama.1986.03370110129041 · Cited by 22
United States Vaccine Research: A Delicate Fabric of Public and Private Collaboration
Marcuse, E. K. (1998) · PEDIATRICS · doi:10.1542/peds.102.4.1002 · Cited by 21
Health Policy and Technological Change: Evidence from the Vaccine Industry
Finkelstein, A. N. (2003) · National Bureau of Economic Research · doi:10.3386/w9460 · Cited by 19
Self-citation
Cited by
Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry
Acemoglu, D., & Linn, J. (2004) · The Quarterly Journal of Economics · doi:10.1162/0033553041502144 · Cited by 967
Acemoglu, D., & Restrepo, P. (2022) · The Review of Economic Studies · doi:10.1093/restud/rdab031 · Cited by 586
The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare
Finkelstein, A. (2007) · The Quarterly Journal of Economics · doi:10.1162/qjec.122.1.1 · Cited by 526
Self-citationDefensive Investments and the Demand for Air Quality: Evidence from the NOx Budget Program
Deschênes, O., Greenstone, M., & Shapiro, J. S. (2017) · American Economic Review · doi:10.1257/aer.20131002 · Cited by 489
Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?
Clemens, J., & Gottlieb, J. D. (2014) · American Economic Review · doi:10.1257/aer.104.4.1320 · Cited by 485
Metadata
- Authors
- Finkelstein, A.
- Venue
- The Quarterly Journal of Economics
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-01
- Volume
- 119
- Issue
- 2
- Pages
- 527-564
- ISSN
- 0033-5533 (ISSN-L)
- 1531-4650
- OpenAlex
- W2172174118
- Cited by
- 321
- References
- 20
- FWCI
- 22.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.